Clinical science| Volume 202, ISSUE 2, P133-138, August 2011

Impact of using triclosan-antibacterial sutures on incidence of surgical site infection



      Surgical site infection is a common complication of surgery. Its morbidities range from delayed healing to systemic sepsis. It has impact on the economy and health care resources.


      This study was a prospective, randomized, double-blinded, controlled multicenter study aimed to compare triclosan-coated polyglactin 910 sutures with polyglactin 910 sutures for the reduction of surgical site infections. This article details the results from the Cairo University center. A total of 450 patients who had undergone different surgical procedures were enrolled; 230 were enrolled in the study group and 220 were enrolled in the control group.


      The study group and the control group were comparable regarding risk factors for surgical site infection. Surgical site infection incidence was 7% in the study group and 15% in the control group (P = .011). The mean extended stay as a result of infection was 3.71 days, with an average cost $91 US per day.


      Use of the triclosan-coated polyglactin 910 antimicrobial suture lead to reduction of surgical site infection and has an impact on saving health care resources. The triclosan-coated polyglactin 910 antimicrobial suture could save $1,517,727 yearly in this single center.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Barie P.S.
        Surgical site infections: epidemiology and prevention.
        Surg Infect Larchmt. 2002; 3: 9-21
        • Leaper D.J.
        • van Goor H.
        • Reilly J.
        • et al.
        Surgical site infection—a European perspective of incidence and economical burden.
        Int Wound J. 2004; 1: 247-273
        • Fry D.E.
        The economic costs of surgical site infection.
        Surg Infect Larchmt. 2002; 3: 37-45
        • Berard F.
        • Gandon J.
        Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors.
        Ann Surg. 1964; 160: 1-192
        • Horan T.C.
        • Gaynes R.P.
        • Martone W.J.
        • et al.
        Definitions of nosocomial surgical site infections; 1992: a modification of CDC definitions of surgical wound infections.
        Infect Control Hosp Epidemiol. 1992; 13: 606-608
        • Mangram A.J.
        • Horan T.C.
        • Pearson M.L.
        • et al.
        Guideline for prevention of surgical site infection.
        Am J Infect Control. 1999; 27: 97-134
        • Rothenburger S.
        • Spangler D.
        • Bhende S.
        • et al.
        In vitro antibacterial evaluation of coated Vicryl plus antibacterial (polyglactin 910) suture (coated polyglactin 910 with triclosan) using zone of inhibition assays.
        Surg Infect Larchmt. 2002; 3: S79-S87
        • Barbolt T.A.
        Chemistry and safety of triclosan and its use as an antibacterial coating on coated Vicryl plus antibacterial (polyglactin 910) suture (coated polyglactin 910 with triclosan).
        Surg Infect Larchmt. 2002; 3: S45-S54
        • Storch M.
        • Scalzo H.
        • Jacinto G.
        Physical and functional comparison of coated Vicryl plus antibacterial (polyglactin 910) suture (coated polyglactin 910 with triclosan) with coated Vicryl (polyglactin 910) suture.
        Surg Infect Larchmt. 2002; 3: S65-S77
        • Storch M.
        • Perry L.C.
        • Davidson J.M.
        • et al.
        A 28-day study of the effect of coated Vicryl plus antibacterial suture (coated polyglactin 910 with triclosan) on wound healing in linear incisional skin wounds.
        Surg Infect Larchmt. 2002; 3: S89-S98
        • Ford H.R.
        • Jones P.
        • Gaines B.
        • et al.
        Intra-operative handling and wound healing: controlled clinical trial comparing coated Vicryl plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated Vicryl suture (polyglactin 910 suture).
        Surg Infect Larchmt. 2005; 6: 3
        • Gilbert P.
        • McBain A.J.
        • Storch M.L.
        • et al.
        Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan.
        Surg Infect Larchmt. 2002; 3: S55-S64
        • Aiello A.E.
        • Marshall B.
        • Levy S.B.
        • et al.
        Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community.
        Antimicrob Agents Chemother. 2004; 48: 2973-2979
        • Altemeier W.A.
        Sepsis in surgery.
        Arch Surg. 1982; 117: 107-112
        • DiPiro J.T.
        • Martindale R.G.
        • Bakst A.
        • et al.
        Infection in surgical patients: effects on mortality, hospitalization, and post-discharge care.
        Am J Health Syst Pharm. 1998; 55: 777-781
        • Edmiston C.E.
        • Seabrook G.R.
        • Goheen M.P.
        • et al.
        Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination?.
        J Am Coll Surg. 2006; 203: 481-498
        • Beltra-Pico R.
        • Alonso-Jimenez L.
        • Castro-Sanchez M.
        • et al.
        Prospective study comparing the incidence of wound infection following appendectomy for acute appendicitis in children: conventional treatment versus reabsorbable antibacterial suture or gentamycin-impregnated collagen sponge.
        Cir Pediatr. 2008; 21: 199-202
        • Justinger C.
        • Moussavian M.R.
        • Schlueter C.
        • et al.
        Antibiotic coating of abdominal sutures and wound infection.
        J Surg. 2009; 145: 330-334
        • Rozzelle C.J.
        • Leonardo J.
        • Li V.
        Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial.
        J Neurosurg Pediatr. 2008; 2: 111-117
        • Fleck T.
        • Moidl R.
        • Blacky A.
        • et al.
        Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations.
        Ann Thorac Surg. 2007; 84: 2139